AbbVie Inc logo

AbbVie Inc

XTER:4AB (USA)   Ordinary Shares
€ 159.40 (-0.76%) Jun 19
50.85
P/B:
37.79
Market Cap:
€ 281.76B ($ 301.63B)
Enterprise V:
€ 333.84B ($ 357.38B)
Volume:
461.00
Avg Vol (2M):
646.00
Trade In:
Volume:
461.00
Avg Vol (2M):
646.00

Business Description

Description
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

Financials (Next Earnings Date:2024-07-26 Est.)

XTER:4AB's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

AbbVie Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 50,286.211
EPS (TTM) (€) 3.119
Beta 0.45
Volatility % 22.41
14-Day RSI 63.97
14-Day ATR (€) 2.70691
20-Day SMA (€) 151.4
12-1 Month Momentum % 20.32
52-Week Range (€) 118.8 - 168.92
Shares Outstanding (Mil) 1,765.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AbbVie Inc Filings

Filing Date Document Date Form
No Filing Data

AbbVie Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

AbbVie Inc Frequently Asked Questions

What is AbbVie Inc(XTER:4AB)'s stock price today?
The current price of XTER:4AB is €159.40. The 52 week high of XTER:4AB is €168.92 and 52 week low is €118.80.
When is next earnings date of AbbVie Inc(XTER:4AB)?
The next earnings date of AbbVie Inc(XTER:4AB) is 2024-07-26 Est..
Does AbbVie Inc(XTER:4AB) pay dividends? If so, how much?
The  Dividend Yield %  of AbbVie Inc(XTER:4AB) is 3.51% (As of Today), Highest Dividend Payout Ratio of AbbVie Inc(XTER:4AB) was 1.41. The lowest was 0.53. And the median was 0.76. The  Forward Dividend Yield % of AbbVie Inc(XTER:4AB) is 3.6%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release